The earlier that cancer is found, the higher the chance of successful treatment and survival. Yet,
for many people, the detection of cancer often happens after a tumor has already progressed to mid
to late stages.
Genetron Health has R&D centers in China and the United States, 2 medical device production bases that have
passed ISO13485:2016 and ISO9001:2015 system certifications, and 4 clinical laboratories bases located in
Shanghai, Chongqing, Guangzhou, and Beijing (CAP accreditation, CLIA certification).